Alison Quinn's Respiro Diagnostics raises GBP 1M for breath-based lung diagnostics
The UK company plans a September 2026 lung cancer clinical study after early proof-of-concept work in mesothelioma patients.
Read the full articleYou might also wanna read
A Pilot Study of the VosCryoTM Breathalyser in Lung Cancer
Conditions : Advanced Lung Cancer Interventions : Other: Expiratory Breath Condensate Collection Sponsors : Sheffield Teaching Hospitals NHS
CGT Catapult teams with Korecyte Bio on low-oxygen detecting CAR-T program
A startup biotech company out of King’s College London is using hypoxia to target solid tumors.
A Study of a New PET Scanner in People With Cancer
Conditions : Non Small Cell Lung Carcinoma NSCLC; Head and Neck Cancer; Prostate Cancer Interventions : Diagnostic Test: Biograph Vision Qua
UK Quantum Biomedical Hub Awarded £902,000 for Clinical Sensing and Imaging Hardware Development
The UK National Quantum Biomedical Research Hub (Q-BIOMED) has been awarded £902,000 ($1.2 million USD) from the Engineering and Physical Sc
iq.fp2.dev·1mo ago
New robotic technology aids in early lung cancer detection
A new tool is being used by doctors with St. Peter's Health Partners (SPHP) in an effort to help improve early detection of lung cancer.
Cancer therapy spinout Myricx Bio agrees to US$1.5B acquisition by Novartis
Myricx Bio, a cancer therapy spinout based on research carried out at the Francis Crick Institute and Imperial College London, has reached a
crick.ac.uk·3d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.